{"schema_version":"secwatch.filing_event.v1","accession":"0001819790-23-000034","form_type":"8-K","ticker":"TARS","cik":"0001819790","company_name":"Tarsus Pharmaceuticals, Inc.","filed_at":"2023-06-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.841777+00:00","generated_at":"2026-06-14T00:31:34.667418+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"low","headline":"Tarsus hosts investor webcast on TP-03 commercialization strategy; no new material financial data disclosed","bullets":["Company hosted Virtual Investor Webcast on June 15, 2023, with corporate presentation on TP-03 for Demodex blepharitis.","Presentation posted to investor section of website; no specific financial results or guidance provided.","No material changes to business or financial condition disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001819790-23-000034","json":"https://secwatch.observer/filing/0001819790-23-000034.json","markdown":"https://secwatch.observer/filing/0001819790-23-000034.md","text":"https://secwatch.observer/filing/0001819790-23-000034.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1819790/000181979023000034/0001819790-23-000034-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1819790/000181979023000034/tars-20230615.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T00:31:34.667418+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}